<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_mh7KCBu"></title>
				<funder>
					<orgName type="full">ALF</orgName>
				</funder>
				<funder>
					<orgName type="full">Beata Borgstr€ om Bolmsj€</orgName>
				</funder>
				<funder>
					<orgName type="full">Region Skåne</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100009780</idno>
				</funder>
				<funder>
					<orgName type="full">Crafoordska</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Beata</forename><surname>Borgstr€ Om Bolmsj€</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Clinical Sciences Malm€ o , Lund University , Sweden ;</note>
								<orgName type="department">Department of Clinical Sciences Malm€ o</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Center for Primary Healthcare Research , Skåne University Hospital , Lund University , Sweden;</note>
								<orgName type="department">Center for Primary Healthcare Research</orgName>
								<orgName type="institution" key="instit1">Skåne University Hospital</orgName>
								<orgName type="institution" key="instit2">Lund University</orgName>
								<address>
									<country>Sweden;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Moa</forename><surname>Wolff</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Clinical Sciences Malm€ o , Lund University , Sweden ;</note>
								<orgName type="department">Department of Clinical Sciences Malm€ o</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Center for Primary Healthcare Research , Skåne University Hospital , Lund University , Sweden;</note>
								<orgName type="department">Center for Primary Healthcare Research</orgName>
								<orgName type="institution" key="instit1">Skåne University Hospital</orgName>
								<orgName type="institution" key="instit2">Lund University</orgName>
								<address>
									<country>Sweden;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Veronica</forename><surname>Milos Nymberg</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Clinical Sciences Malm€ o , Lund University , Sweden ;</note>
								<orgName type="department">Department of Clinical Sciences Malm€ o</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Center for Primary Healthcare Research , Skåne University Hospital , Lund University , Sweden;</note>
								<orgName type="department">Center for Primary Healthcare Research</orgName>
								<orgName type="institution" key="instit1">Skåne University Hospital</orgName>
								<orgName type="institution" key="instit2">Lund University</orgName>
								<address>
									<country>Sweden;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Magnus</forename><surname>Sandberg</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> Department of Health Sciences , Lund University , Sweden</note>
								<orgName type="department">Department of Health Sciences</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrik</forename><surname>Midl€ Ov</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Clinical Sciences Malm€ o , Lund University , Sweden ;</note>
								<orgName type="department">Department of Clinical Sciences Malm€ o</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Center for Primary Healthcare Research , Skåne University Hospital , Lund University , Sweden;</note>
								<orgName type="department">Center for Primary Healthcare Research</orgName>
								<orgName type="institution" key="instit1">Skåne University Hospital</orgName>
								<orgName type="institution" key="instit2">Lund University</orgName>
								<address>
									<country>Sweden;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susanna</forename><surname>Calling</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Clinical Sciences Malm€ o , Lund University , Sweden ;</note>
								<orgName type="department">Department of Clinical Sciences Malm€ o</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Center for Primary Healthcare Research , Skåne University Hospital , Lund University , Sweden;</note>
								<orgName type="department">Center for Primary Healthcare Research</orgName>
								<orgName type="institution" key="instit1">Skåne University Hospital</orgName>
								<orgName type="institution" key="instit2">Lund University</orgName>
								<address>
									<country>Sweden;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>35</label> Clinical Research Centre (CRC) , building 28 , floor 11 , Jan Waldenstr€ oms gata Skåne University Hospital</note>
								<orgName type="department">Clinical Research Centre (CRC)</orgName>
								<orgName type="institution">Skåne University Hospital</orgName>
								<address>
									<addrLine>building 28 floor 11 Jan Waldenstr€ oms gata</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">MALM € O , Sweden.</note>
								<orgName type="institution">MALM €</orgName>
								<address>
									<postBox>O</postBox>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">09A17039BC46D434E8D4F36E96A2AA3D</idno>
					<idno type="DOI">10.1080/02813432.2020.1794392</idno>
					<note type="submission">Received 13 August 2019 Accepted 18 May 2020</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T13:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_Q4hvgJY">Primary health care</term>
					<term xml:id="_ZbPb2hd">hypertension</term>
					<term xml:id="_rsVFxKP">RCT</term>
					<term xml:id="_uB69ruK">feasibility study</term>
					<term xml:id="_H6UjCCn">reminder systems</term>
					<term xml:id="_sjTwKNt">mobile phones</term>
					<term xml:id="_H6uXMJD">lifestyle advice</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_dfRXtbf"><p xml:id="_5gvJJrh"><s xml:id="_c2C4XF7">Objective: To evaluate the feasibility of a randomized controlled pilot study with lifestyle-promoting text messages as a treatment for hypertension in primary care.</s><s xml:id="_A4nbXUX">Design: Randomized controlled pilot trial.</s><s xml:id="_v7BdcBz">Setting: Three primary health care centers in southern Sweden.</s><s xml:id="_QfqJQSr">Subjects: Sixty patients aged 40-80 years with hypertension were included.</s><s xml:id="_3feBhAT">Main outcome measures: Feasibility of the pilot study, i.e. recruitment rate, dropout rate and eligibility criteria.</s><s xml:id="_p736um6">Secondary outcomes were change in blood pressure and other cardiovascular risk factors.</s><s xml:id="_QSWyw8U">Methods: Thirty participants were randomized to the intervention group with four lifestyle-promoting text messages sent every week for six months.</s><s xml:id="_jcd2ydf">The control group received usual care.</s><s xml:id="_RKaPs46">The baseline and follow-up visits for all 60 patients included measurements of blood pressure, anthropometrics, blood tests and a self-reported questionnaire.</s><s xml:id="_9tVjHS5">Results: All feasibility criteria (recruitment rate (!55%), dropout rate ( 15%) and eligibility (60 eligible patients during the four-month inclusion period) for the pilot study were fulfilled.</s><s xml:id="_jDg6Kb3">This means that a larger study with a similar design may be conducted.</s><s xml:id="_8ZVyazS">After six months, there were no significant improvements in cardiovascular risk factors.</s><s xml:id="_azn5Vax">However, we found favorable trends for all secondary outcomes in the intervention group as compared to the control group.</s><s xml:id="_qhrFFgH">Conclusion: Lifestyle modification in patients with hypertension is important to reduce cardiovascular risk.</s><s xml:id="_X4HbVpT">However, primary healthcare has limited resources to work with modifying lifestyle habits.</s><s xml:id="_uE9XW2W">This is the first pilot study to test the feasibility of text message-based lifestyle intervention in patients with hypertension in Swedish primary healthcare.</s><s xml:id="_se5fsnc">Whether significant improvement in cardiovascular risk factors may be achieved in a larger study population remains to be evaluated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VSTDUaG">KEY POINTS</head><p xml:id="_gnMNu7j"><s xml:id="_WAVdPdH">This pilot randomized controlled trial (RCT) is the first study to evaluate the feasibility of text message-based lifestyle advice to patients with hypertension in Swedish primary healthcare.</s></p><p xml:id="_wCwByKA"><s xml:id="_bSDvheX">All feasibility criteria for the pilot study were fulfilled.</s><s xml:id="_gK4cZ6s">This outcome means that a larger study with a similar design may be conducted.</s></p><p xml:id="_CujVn2A"><s xml:id="_4qHnJky">The study was not powered to find significant changes in cardiovascular risk factors.</s><s xml:id="_KuutZ86">Nevertheless, after six months we found favorable trends for all secondary outcomes in the intervention group compared to control.</s></p><p xml:id="_3TSqS9F"><s xml:id="_fbszyJ5">If a future larger study can show significant results, this intervention could serve as a useful tool in everyday primary healthcare.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="634.32" lry="833.04"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="609.449" lry="793.701"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Mbwd75k">RESEARCH ARTICLE</head><p xml:id="_VNNctrs"><s xml:id="_nCf88aY">Text message-based lifestyle intervention in primary care patients with hypertension: a randomized controlled pilot trial</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xse5C4T">Introduction</head><p xml:id="_XXxcsCx"><s xml:id="_NJ6EqDf">The globalization of unhealthy lifestyles and demographic aging of the world's population has contributed to the fact that high blood pressure (BP) is classified by the World Health Organization as the world's leading risk for mortality <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_BTsmbJA">Although most high-income countries have had favorable trends with decreasing prevalence of high BP, a global increased prevalence of raised BP has been shown in a recent large meta-analysis <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_KkAfhKe">Hypertension is a key risk factor for cardiovascular diseases (CVD) <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_grF6bPQ">Modifiable lifestyle risk factors associated with hypertension, including smoking, unhealthy diet and physical inactivity, account for approximately 80% of CVD <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_umCwPW4">The fact that 30-40% of individuals with hypertension have additional metabolic risk factors, such as dyslipidemia, insulin resistance and elevated blood-glucose <ref type="bibr" target="#b4">[5]</ref>, multiplies the risk for CVD <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_CE7X8VU">In most cases, lifestyle intervention can reverse or reduce a patient's unfavorable metabolic profile <ref type="bibr" target="#b6">[7]</ref>.</s></p><p xml:id="_cFUwMf7"><s xml:id="_67f2SYz">Primary healthcare centers in Sweden handle the majority of patients with hypertension.</s><s xml:id="_xnxx39y">However, there are limited resources to support the lifestyle changes needed for primary and secondary prevention of CVD.</s></p><p xml:id="_tMqdWa7"><s xml:id="_EnPrqjs">Interventions done using SMS (Short Message Services) have been shown to significantly improve compliance to medications, follow-up rate and disease monitoring <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_4rNdTG9">A Swedish study, which used an interactive mobile phone intervention on BP, showed improved BP control by self-management of hypertension <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_WF3cUgD">A randomized controlled trial (RCT) of CVD patients, who got weekly lifestyle focused SMS messages during six months, showed positive effects on BP, body mass index (BMI), physical activity and smoking cessation <ref type="bibr" target="#b11">[12]</ref>, as compared to the control group.</s><s xml:id="_zEe7nzB">Thus, communication by telehealth, e.g.</s><s xml:id="_C7rz9KH">SMS could constitute an additional tool to reach patients for lifestyle advice.</s><s xml:id="_mB4dawq">SMS is a common, convenient and cheap method of communication that can reach a large proportion of a primary care population.</s></p><p xml:id="_ndBMjfR"><s xml:id="_SvqEuXT">Although positive results have been indicated for text messaging interventions for CVD risk factors, lifestyle-promoting messages have not been evaluated as a treatment for hypertension in primary care.</s><s xml:id="_h4B9RC4">We conducted this pilot study to evaluate the feasibility of an RCT with SMS intervention to promote lifestyle changes in individuals with hypertension in primary healthcare.</s><s xml:id="_WvkmBD7">A secondary objective was to evaluate change on BP and other objective measures of cardiovascular risk and general health.</s><s xml:id="_6vNSyPq">A third objective was to evaluate the patients' acceptability and utility of the SMS intervention.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ucUjbhF">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xefk2FG">Trial design and participants</head><p xml:id="_XKR5QVm"><s xml:id="_GjPysBj">We conducted a three-center parallel-group RCT with a six month follow-up.</s><s xml:id="_dyBm4P2">A Case Report Form (CRF) was followed and controls were made by an external research monitor.</s><s xml:id="_ukE9WkY">The study was registered at ClinicalTrials.gov</s><s xml:id="_Jths2xC">(NCT03442257).</s></p><p xml:id="_ErZSYgm"><s xml:id="_pv89nCG">In March-June 2018, patients aged 40-80 years with diagnosed hypertension were invited consecutively during doctor or nurse visits at three primary health care centers in southern Sweden.</s><s xml:id="_4xZyCKy">The three primary health care centers differed in socioeconomic status (according to predefined Care Need Index) <ref type="bibr" target="#b12">[13]</ref> and healthcare burden (Adjusted Clinical Groups) <ref type="bibr" target="#b13">[14]</ref>.</s><s xml:id="_Q8xvKhT">Patients who were interested in participating were given written information about the study and were contacted within two weeks by a research assistant to provide further information.</s><s xml:id="_8TTd24p">Those who were willing to participate were invited to the primary health care centers for the baseline visit, where a written informed consent was signed before the examination.</s></p><p xml:id="_k6pxD7C"><s xml:id="_kqQvrJ4">Patients were eligible if they fulfilled the following criteria: 40-80 years, had documented hypertension (defined by the International classification of disease ICD-10, diagnose code I10.9) and owned a mobile phone compatible with SMS.</s><s xml:id="_ATwpwgW">Exclusion criteria were: history of prior CVD (myocardial infarction, stroke, transient ischemic attack (TIA), intermittent claudication or abdominal aortic aneurysm) reported by recruiting physician or by the patient in the questionnaire; BP at baseline visit !180/110 mmHg or systolic BP &lt;120 mmHg; serious illness with short life expectancy (&lt;1 year); dementia/serious psychiatric disease or predicted inability to comply with the study protocol (e.g.</s><s xml:id="_6gN9Kjw">language difficulties or interpreter needs).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9rHA92X">Randomization</head><p xml:id="_n93dAHp"><s xml:id="_fAye99w">Randomization was performed after completion of baseline assessments and questionnaires.</s><s xml:id="_aGjzxV5">A computergenerated random number schedule with block sizes of four was prepared.</s><s xml:id="_bCFNFkb">To ensure allocation concealment, a collaborator outside of the research project performed the randomization.</s><s xml:id="_vsbMvna">Information about group affiliation was delivered to the patients by postal mail.</s><s xml:id="_wUPYxZw">The research assistant, the patients' primary care physicians, as well as the researchers were blinded to group allocation.</s><s xml:id="_NdcVfjd">If the patients had questions or wanted to exit the study, they could call a telephone number and speak to a collaborator not involved in the data analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mE6Mw5C">Intervention</head><p xml:id="_zbFmy7n"><s xml:id="_z8y2CHF">The intervention consisted of regularly delivered SMS messages that aimed to remind, encourage and motivate patients to pursue healthy lifestyle changes.</s><s xml:id="_fzw4sTZ">After baseline measurement, participants in the intervention group, in addition to their usual anti-hypertensive treatment, received four semi-personalized SMS messages per week for six months.</s><s xml:id="_SEZS5aM">Each week, the participants received one SMS with health information concerning each of the following groups: A. Physical activity, B. Tobacco use, C. Dietary habits, and D. Cardiovascular health in general, except for nonsmokers who, instead of the tobacco use-SMS, got one extra randomly selected SMS from group A, C or D (Table <ref type="table" target="#tab_0">1</ref>).</s><s xml:id="_eFrQx96">The messages were sent at random times during daytime between 9 AM and 7 PM.</s><s xml:id="_zCnvun5">The SMS messages were initially developed by the authors using lifestyle recommendations based on Swedish national guidelines <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>, and edited by an expert group at the Centre for Lifestyle Habits in Malm€ o.</s><s xml:id="_Mn9yn8w">This group included physiotherapists, dieticians and a physician specially trained in encouraging healthy lifestyle habits.</s></p><p xml:id="_QpKRudS"><s xml:id="_TZNAR4Z">The control group received usual care.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_h9zeNSF">Measurements</head><p xml:id="_dWsjnZe"><s xml:id="_PmDtdA5">Data were collected at baseline and after six months.</s><s xml:id="_mszEt68">BP was measured following the guidelines of the European Society of Hypertension <ref type="bibr" target="#b17">[18]</ref>, i.e. in the right arm in a sitting position after 5-10 min of rest with validated electronic blood pressure devices (Omron 705-IT, Omron Health Care Co., Kyoto, Japan).</s><s xml:id="_Dp3T366">The mean of two readings was calculated (mean of three readings when the first and second readings differed by &gt;5 mm Hg).</s><s xml:id="_rcJbGzE">Heart rate, weight, height, BMI, waist circumference, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and HbA1c were also measured at baseline and at six months.</s><s xml:id="_Uet22a3">Furthermore, the patients completed a short questionnaire for evaluation of medical history, medication, tobacco use, self-rated health (SRH) and health-related quality of life.</s><s xml:id="_G2fm99r">SRH was measured by a Likert scale via a simple question 'How would you rate your general health?' with five response options: very good, good, fair, poor or very poor <ref type="bibr" target="#b18">[19]</ref>.</s><s xml:id="_PcahWUa">Health-related quality of life was measured by the EQ5D-5L questionnaire, including the EQ visual analogue scale 0-100 (100 ¼ the best health you can imagine) (EQ VAS) <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s xml:id="_77nnPDF">The EQ5D-5L questionnaire rates the level of impairment across five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and is measured on a five graded Likert scale.</s><s xml:id="_sQUVzb4">EQ-5D-5L index value was calculated through EQ-5D-5L Index Value Calculator developed by the EuroQol Group <ref type="bibr" target="#b21">[22]</ref>.</s></p><p xml:id="_E5e2fXY"><s xml:id="_BSwjqvN">To evaluate the experience of the SMS messages, intervention participants received a separate questionnaire by postal mail 6-12 months after the intervention was completed.</s><s xml:id="_ENDjZSq">The questionnaire contained 13 statements about the acceptability and utility of the intervention and the participants answered by checking the most appropriate option on a five graded Likert scale (from disagree to strongly agree).</s><s xml:id="_gAkHt9y">The participants were also able to leave comments in free text and to give examples of SMS messages that they had favored or disliked.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AVRa2b2">Outcomes</head><p xml:id="_gUtXSPH"><s xml:id="_7TWYTuu">The primary outcome was feasibility of the study protocol, as defined prior to the study by the following three criteria <ref type="bibr" target="#b22">[23]</ref>:</s></p><p xml:id="_sYa69J3"><s xml:id="_vjKWRAj">1. Recruitment rate.</s><s xml:id="_vUYjQ7v">A recruitment rate of !55% was considered successful <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_2UNEgcv">2. Dropout rate.</s><s xml:id="_3wYTCmQ">A maximum of 15% dropout rate was considered acceptable, according to the power calculation for the full-scale study.</s><s xml:id="_Dx3hSnR">3. Eligibility criteria.</s><s xml:id="_CGUKQEu">The eligibility criteria were considered sufficient if 60 patients could be included .</s><s xml:id="_hWx4Y6w">Home blood pressure monitoring with an upper arm cuff is a good complement to blood pressure measurement at the primary healthcare center.' 'Hi <ref type="bibr">[NAME]</ref>.</s><s xml:id="_KGPtdrs">High blood pressure is the single most important treatable risk factor for cardiovascular disease, and that is why we strive to reach a normal blood pressure with medication.'</s></p><p xml:id="_SUwEwpF"><s xml:id="_uxpz5P7">from the three primary health care centers during the study period of four months.</s></p><p xml:id="_8hfwpHq"><s xml:id="_Erku3cH">If all three feasibility criteria were fulfilled, a larger study could be conducted without further changes in the protocol.</s><s xml:id="_ttFW5wa">If some of the criteria were not fulfilled, the protocol and design will be changed accordingly.</s></p><p xml:id="_svfC7K5"><s xml:id="_uX5GcMb">The secondary outcomes were: change in systolic and diastolic BP, BMI, waist circumference, total cholesterol, LDL, HDL, tobacco use, HbA1c, SRH, EQ5D-5L and EQ VAS.</s><s xml:id="_6RnWhJT">The acceptability and utility of the SMS intervention were evaluated through questionnaires.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FvYsuc3">Statistical analysis</head><p xml:id="_vXTCWTE"><s xml:id="_zh8Yuvj">Data were analyzed using IBM SPSS Statistics 25 (IBM Corp., Released 2017, Armonk, NY, USA).</s><s xml:id="_yqdtUYq">For calculation of differences between groups; 2 tailed t-test was used for continuous variables, Mann-Whitney U test for categorical variables, and Pearson Chi-Square test for discrete variables.</s><s xml:id="_bawcAgN">The EQ5D-5L index was calculated using EQ5D-5L index value for UK, through EQ-5D-5L Index Value Calculator developed by the EuroQol Group <ref type="bibr" target="#b21">[22]</ref>.</s></p><p xml:id="_vHeDCkA"><s xml:id="_4VxCpdN">Mean differences in end points between intervention and control groups at six month follow up were calculated by ANCOVA, with baseline values used as covariates <ref type="bibr" target="#b23">[24]</ref>.</s><s xml:id="_zxuJUrU">No other covariates were added, as the study sample was too small.</s></p><p xml:id="_YSVG23b"><s xml:id="_xMC49fx">Prior to the study, we estimated that a total number of 60 patients would be sufficient to evaluate the feasibility of the intervention and the logistics of the assessments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_b5DnEAB">Ethical considerations</head><p xml:id="_MGfbSHm"><s xml:id="_cAB7vYN">Patients provided written informed consent at the baseline visit.</s><s xml:id="_jfbyXkb">The study was approved by the Regional Ethical Review Board in Lund, Sweden (Dnr: 2017/674).</s><s xml:id="_TeR4tRA">If extreme measures were found at baseline or follow-up visit, the patient's primary care physician was informed.</s><s xml:id="_KqR2JQR">For the follow-up questionnaire, an additional ethical approvement was obtained (Dnr: 2019-01833) and a written consent form was provided by the participants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4zcec4t">Results</head><p xml:id="_hBk2AHu"><s xml:id="_cCThnwG">A total of 96 patients were invited to participate in the study via a simple question by the nurse or doctor during an ordinary visit at the primary health care center (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_3S9qVqW">One third (n ¼ 32) declined.</s><s xml:id="_TRu87qn">Reasons for declining participation were not registered at this point.</s><s xml:id="_VsnbGSe">At the baseline assessment, four patients did not meet the inclusion criteria (too low BP (n ¼ 3), too high BP (n ¼ 1)).</s><s xml:id="_g9Mqhms">Sixty patients were allocated to the study and two were lost to follow-up.</s><s xml:id="_bNQ3Uvp">Moreover, one participant in the intervention group did not receive the allocated intervention (information was never sent to the SMS company) and is therefore not included in the analysis.</s><s xml:id="_fbDCSvs">All 29 participants who received the SMS intervention answered the acceptability and utility questionnaire.</s></p><p xml:id="_E5F7jeJ"><s xml:id="_Arg5QNy">Mean age was 67.0 years and 57% were women, 82% were overweight (BMI ! 25 kg/m 2 , n ¼ 49) and large waist circumference was found in 91% of the women (!88 cm) and in 69% of the men (!102cm).</s><s xml:id="_PhdszYE">Mean BP was 141/79 mm Hg.</s><s xml:id="_Wa7dbKh">There were no significant differences between the two groups at baseline.</s><s xml:id="_qVPM3fz">All participants except two were on antihypertensive medication (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p xml:id="_Uqum6uB"><s xml:id="_zMCaVZU">All three feasibility criteria were fulfilled: Recruitment rate !55% (60/96 ¼ 63%); dropout rate &lt;15% (2/60 ¼ 3%) and 60 patients were included during the four-month inclusion period.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MMAtVuS">Effect on BP and other CVD risk factors</head><p xml:id="_KZXpqNU"><s xml:id="_4vVf58y">Table <ref type="table" target="#tab_2">3</ref> shows the follow-up measures (adjusted for baseline) and mean differences between the groups for all CVD risk factor outcome variables.</s><s xml:id="_8gsUhXT">There were no significant differences in mean change of any outcome variables between the SMS and control groups.</s><s xml:id="_55zhZy4">However, all secondary outcome parameters in the SMS group showed favorable trends compared to the control group (Table <ref type="table" target="#tab_2">3</ref>).</s><s xml:id="_AvrXzxt">Three participants were smokers at baseline (SMS group n ¼ 2, control group n ¼ 1), none of these had quit smoking at follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_F32rsZx">Acceptability and utility of the intervention</head><p xml:id="_ZZCzGZj"><s xml:id="_ttHFv5g">All of the 29 patients who got the SMS intervention answered the acceptability and utility questionnaire.</s><s xml:id="_a3ufaj5">Seventy-six percent agreed (answered agree or strongly agree) that the SMS messages gave a reminder of healthy lifestyle habits, and 35% agreed that the SMS messages gave new knowledge (Supplementary Figures <ref type="figure" target="#fig_0">1</ref> and <ref type="figure">2</ref>).</s><s xml:id="_fYKt7Ra">More than one third (38%) stated that the SMS messages made them more physically active and one fourth (24%) had changed to healthier dietary habits.</s><s xml:id="_ZXjxnCR">Ninety-seven percent read all the text messages for the first three months and about 93% also during the last three months.</s><s xml:id="_hNAERMA">Half of the intervention group (52%) saved the text messages and 45% showed the messages to family and friends.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HjnVrZp">Discussion</head><p xml:id="_ADkYpKD"><s xml:id="_raMgA3v">This pilot study showed that all three feasibility criteria were fulfilled.</s><s xml:id="_TxY9DAx">This outcome means that a future larger study can be conducted without any major changes being made to the study protocol.</s><s xml:id="_nnjBdwH">The study also showed that the intervention was accepted to a high degree by the participants.</s><s xml:id="_kNHAGbg">A favorable trend was seen for all pre-defined outcome variables which indicates that the lifestyle advice delivered via SMS may have contributed to the improvement.</s><s xml:id="_MCdB7Ak">Hence, there is a need for larger RCTs to further evaluate the effects of this intervention on CVD risk factor variables.</s></p><p xml:id="_xDgajUA"><s xml:id="_yCDJAR2">Three quarters of the patients in the intervention group stated that the SMS messages gave a reminder  of healthy lifestyle habits and 35% thought that the SMS messages gave them new knowledge (Supplementary Figures <ref type="figure" target="#fig_0">1</ref> and <ref type="figure">2</ref>).</s><s xml:id="_Keg5HV4">Nowadays, the time for working with lifestyle modification in primary healthcare is very limited <ref type="bibr" target="#b24">[25]</ref>.</s><s xml:id="_A7Y6Xn5">The commonly used methods are patient-centered with the aim of empowering patients to change lifestyle habits, but primary care personnel have reported a lack of skills in lifestyle counseling and experienced patients' unwillingness to change lifestyle habits <ref type="bibr" target="#b25">[26]</ref>.</s></p><p xml:id="_S6nEngT"><s xml:id="_48HWmFE">If a future larger study was to show significant improvement in lifestyle habits and CVD risk factors, our SMS tool may be implemented in everyday primary healthcare for patients with hypertension thus providing a complementary tool for lifestyle changes.</s><s xml:id="_UnjAw2b">The study was designed to observe the effect of a simple one-way SMS without an interactive approach, as we believe this could be used more widely in the clinical setting by not requiring additional personnel involvement.</s><s xml:id="_Y9jTe4g">In addition, an earlier published threearmed RCT (control, simple text messages, interactive text messages) did not demonstrate any further effect on BP control in the group with interactive text messages <ref type="bibr" target="#b26">[27]</ref>.</s></p><p xml:id="_hm24pzx"><s xml:id="_qmaC9yJ">In the acceptability and utility questionnaire, some of the participants asked for information that is more advanced, and for more web links to follow.</s><s xml:id="_6z26FkG">This could perhaps enhance the impact of the intervention.</s><s xml:id="_YyhjCky">However, the aim of this study was to create an intervention suitable and accessible for a wide range of subgroups of the population, e.g.</s><s xml:id="_dzBSKzR">people with simple mobile phones, elderly people not used to advanced mobile phone applications and people with different educational levels or technical skills.</s><s xml:id="_zMP4cjb">With this widespread approach, it is inevitable there will be different opinions on the intervention.</s><s xml:id="_EnTDzAS">Even though the recruitment criteria were fulfilled, the recruitment process took more time than expected.</s><s xml:id="_dtwuHmt">This was mainly due to lack of eligible patients because of the exclusion criterion of prior CVD.</s><s xml:id="_PnJvEyG">To be able to conduct a future larger study within a reasonable time, we plan to expand the inclusion criteria to patients with prior CVD.</s><s xml:id="_k9Xwbpt">These patients may even be more aware and motivated to implement lifestyle changes, and a recent Australian study has shown positive results from SMS lifestyle intervention in patients with prior myocardial infarction <ref type="bibr" target="#b11">[12]</ref>.</s></p><p xml:id="_zXAYsBj"><s xml:id="_xTEANkz">Due to the nature of the intervention in this study, it was not possible to blind the participants <ref type="bibr" target="#b27">[28]</ref>.</s><s xml:id="_n5xch7K">We cannot rule out the effect on the patients just being in the intervention group in an RCT (performing bias).</s><s xml:id="_nWPWyXH">Vice versa applies to the patients in the control group, knowing they signed up for a study with text messages, and ending up in the control group, not receiving any messages.</s><s xml:id="_FcfCgtz">A solution to this could be a delayed intervention for the control group or crossover design, but this would double the time for the study and was therefore not considered to be feasible in this study.</s></p><p xml:id="_jjrBpTz"><s xml:id="_WeXq5Gs">Three primary health care centers from different areas were chosen and they differed by both Adjusted Clinical Groups and Care Need Index.</s><s xml:id="_e55YVkz">Thus, the study reflected a population with a range of disease burden and socioeconomic status.</s><s xml:id="_uVcpYf8">However, in this small pilot study, it is not possible to evaluate the generalizability to a larger population.</s></p><p xml:id="_fdP7dSB"><s xml:id="_fHGx6WY">In conclusion, this pilot study met all feasibility criteria for a full-scale study and the participants were positive to a high extent regarding the SMS intervention.</s><s xml:id="_6Ja3yTx">A full-scale study is needed to evaluate whether a significant improvement of cardiovascular risk factors may be achieved in a primary healthcare population.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_7CTjxJr"><s xml:id="_X9UCFzf">Figure 1.</s><s xml:id="_n4wvMBC">Enrollment of participants.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s xml:id="_TZ2guAF">Examples of text messages sent to the intervention group.NAME].Regular physical activity improves both blood pressure and blood lipids.In addition, inflammation in the vessels may decrease, which contributes to the reduced risk of cardiovascular disease.' 'Hi[NAME].Reducing your sedentary time improves your health.Make a break by stretching your legs every 30 minutes when you are sedentary for a longer period.'Tobaccouse'Hi[NAME].Did you know that your blood pressure and heart rate decrease already 20 minutes after smoking cessation?' 'Hi[NAME].Instead of taking a smoking break, try to go for a brisk walk.' Diet 'Hi[NAME].Wholemeal intake may reduce the risk for type 2 diabetes, cardiovascular disease and colorectal cancer.' 'Hi[NAME].</s><s xml:id="_qDPaW3Q">Too much salt intake may increase your blood pressure, which in turn increases the risk for myocardial infarction, heart failure, stroke and kidney failure.'</s></p></div></figDesc><table><row><cell>Category</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_nUGGkfe"><s xml:id="_qFcbRfs">Baseline characteristics of the intervention group and the control group.</s></p></div></figDesc><table><row><cell></cell><cell>SMS group</cell><cell>Control group</cell><cell></cell></row><row><cell></cell><cell>n ¼ 30</cell><cell>n ¼ 30</cell><cell>p Value</cell></row><row><cell>Age, years</cell><cell>69.1 (5.4)</cell><cell>64.8 (10.5)</cell><cell>0.05</cell></row><row><cell>Female gender, n (%) BMI, kg/m 2</cell><cell>15 (50%) 28.6 (5.1)</cell><cell>19 (63%) 29.7 (4.5)</cell><cell>0.30 0.41</cell></row><row><cell>Waist circumference, cm</cell><cell cols="2">102.5 (14.6) 100.1 (12.5)</cell><cell>0.50</cell></row><row><cell>SBP, mmHg</cell><cell cols="2">141.7 (13.8) 141.1 (13.8)</cell><cell>0.86</cell></row><row><cell>DBP, mmHg</cell><cell>78.7 (8.9)</cell><cell>79.9 (9.5)</cell><cell>0.62</cell></row><row><cell>HbA1c, mmol/mol</cell><cell>39.4 (9.3)</cell><cell>38.5 (5.1)</cell><cell>0.64</cell></row><row><cell>Total cholesterol, mmol/l</cell><cell>5.1 (1.1)</cell><cell>5.2 (1.1)</cell><cell>0.70</cell></row><row><cell>LDL, mmol/l</cell><cell>3.3 (1.0)</cell><cell>3.4 (1.0)</cell><cell>0.60</cell></row><row><cell>HDL, mmol/l</cell><cell>1.6 (0.6)</cell><cell>1.5 (0.4)</cell><cell>0.49</cell></row><row><cell>Number of antihypertensive drugs</cell><cell>1.7 (0.9)</cell><cell>1.6 (0.7)</cell><cell>0.74</cell></row><row><cell>EQ5D-5L index</cell><cell>0.84 (0.15)</cell><cell>0.83 (0.13)</cell><cell>0.72</cell></row><row><cell>EQ VAS 0-100</cell><cell>88.5 (12.1)</cell><cell>83.2 (12.4)</cell><cell>0.10</cell></row><row><cell>SRH 1-5, median (SD)</cell><cell>2 (0.8)</cell><cell>2 (0.6)</cell><cell>0.07  §</cell></row><row><cell>Means (SD) unless stated otherwise.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">BMI: body mass index; DBP: diastolic blood pressure; SBP: systolic blood</cell></row><row><cell>pressure; SRH: self-rated health.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">2 tailed t-test for continuous variables,</cell><cell></cell><cell></cell></row></table><note xml:id="_x8TN9fM"><p><s xml:id="_MNzzcvx">§ Mann-Whitney U test for categorical variables, Pearson Chi-Square test for discrete variables.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s xml:id="_Mac9YRj">Outcome variables at six months follow up, adjusted for baseline values, and mean difference between SMS group and control group, One-way ANCOVA analysis.: body mass index; DBP: diastolic blood pressure; SBP: systolic blood pressure; SRH: self-rated health.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Adjusted mean (95 % CI)</cell><cell></cell><cell></cell></row><row><cell>Parameter</cell><cell>SMS group (n ¼ 29)</cell><cell>Control group (n ¼ 28)</cell><cell>Mean difference: SMS-control (95 % CI)</cell><cell>p Value for difference</cell></row><row><cell>Systolic BP, mm Hg</cell><cell>140 (136-144)</cell><cell>144 (140-148)</cell><cell>À4 (À10 to 2)</cell><cell>0.19</cell></row><row><cell>Diastolic BP, mm Hg BMI, kg/m 2</cell><cell>78 (75-81) 28.7 (28.4-29.1)</cell><cell>79 (76-81) 29.1 (28.7-29.5)</cell><cell>À1 (À5 to 3) À0.4 (À0.9 to 0.1)</cell><cell>0.70 0.13</cell></row><row><cell>Waist circumference, cm</cell><cell>100.5 (99.1-102.0)</cell><cell>102.1 (100.7-103.6)</cell><cell>À1.6 (À3.7 to 0.4)</cell><cell>0.12</cell></row><row><cell>HbA1c, mmol/mol</cell><cell>37.4 (35.1-39.6)</cell><cell>38.5 (36.2-40.8)</cell><cell>À1.1 (À4.3 to 2.1)</cell><cell>0.50</cell></row><row><cell>Total cholesterol, mmol/l</cell><cell>5.0 (4.8-5.1)</cell><cell>5.2 (5.0-5.4)</cell><cell>À0.2 (À0.5 to 0.1)</cell><cell>0.14</cell></row><row><cell>LDL, mmol/l</cell><cell>3.1 (2.9-3.3)</cell><cell>3.3 (3.1-3.5)</cell><cell>À0.2 (À0.4 to 0.1)</cell><cell>0.23</cell></row><row><cell>HDL, mmol/l</cell><cell>1.6 (1.5-1.6)</cell><cell>1.5 (1.4-1.6)</cell><cell>0.1 (À0.0 to 0.2)</cell><cell>0.10</cell></row><row><cell>EQ5D-5L index</cell><cell>0.8 (0.8-0.9)</cell><cell>0.8 (0.8-0.9)</cell><cell>0.01 (À0.04 to 0.05)</cell><cell>0.83</cell></row><row><cell>EQ VAS</cell><cell>88 (84-92)</cell><cell>82 (78-86)</cell><cell>6 (0 to 12)</cell><cell>0.06</cell></row><row><cell>SRH 1-5</cell><cell>1.9 (1.7-2.2)</cell><cell>2.0 (1.8-2.3)</cell><cell>À0.1 (À0.4 to 0.3)</cell><cell>0.70</cell></row></table><note xml:id="_ap49sP4"><p><s xml:id="_VgqhQXh">BMI</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_hrvK3jd">Acknowledgements</head><p xml:id="_AsPHp2u"><s xml:id="_wwEe5S6">The authors would like to thank <rs type="institution">Center for Lifestyle Habits (Kunskapscentrum levnadsvanor och sjukdomsprevention)</rs> for review and editing of the text messages; <rs type="person">Marie Mårtensson Ruscic</rs> for research monitoring of the project; <rs type="person">Eva Lindel€</rs> ow for the invaluable work with the questionnaires; <rs type="person">Patrick Reilly</rs> for language revision.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_CPYSHPP">Funding</head><p xml:id="_sAgKfmu"><s xml:id="_NJ7KRzt">This work was supported by <rs type="funder">ALF</rs> funding from <rs type="funder">Region Skåne</rs> awarded to <rs type="person">Susanna Calling</rs>, grants from <rs type="funder">Crafoordska</rs> stiftelsen to <rs type="funder">Beata Borgstr€ om Bolmsj€</rs> o, and <rs type="funder">ALF</rs> funding from <rs type="funder">Region Skåne</rs> awarded to <rs type="person">Patrik Midl€</rs> ov.</s></p></div>
			</div>
			<listOrg type="funding">
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_zj2RmRb">Disclosure statement</head><p xml:id="_snaq6aP"><s xml:id="_eNUKCwZ">No potential conflict of interest was reported by the author(s).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<idno type="DOI">10.2471/blt.09.070565</idno>
		<title level="m" xml:id="_meu9Uge">Global health risks: mortality and burden of disease attributable to selected major risks</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Global health risks: mor- tality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_SY9r9hU">Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19Á1 million participants</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bentham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Cesare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vbJ7HtF">Lancet</title>
		<imprint>
			<biblScope unit="volume">389</biblScope>
			<biblScope unit="page" from="37" to="55" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou B, Bentham J, Di Cesare M, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement stud- ies with 19Á1 million participants. Lancet. 2017;389: 37-55.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_Y56YW7e">Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gakidou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Afshin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Abajobir</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bdj.2015.751</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vdYRnpf">Lancet</title>
		<imprint>
			<biblScope unit="volume">390</biblScope>
			<biblScope unit="page" from="1345" to="1422" />
			<date type="published" when="2016">2016. 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gakidou E, Afshin A, Abajobir AA, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a sys- tematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345-1422.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<idno type="DOI">10.2471/b09509</idno>
		<title level="m" xml:id="_dNN4BWs">Global status report on noncommunicable diseases 2014</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_wcqUxTR">Prognostic value of the metabolic syndrome in essential hypertension</title>
		<author>
			<persName><forename type="first">G</forename><surname>Schillaci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pirro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vaudo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2003.12.049</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MRpmks2">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1817" to="1822" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schillaci G, Pirro M, Vaudo G, et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol. 2004;43:1817-1822.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_vYcyFdC">International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity</title>
		<author>
			<persName><forename type="first">K</forename><surname>Alberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Eckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Grundy</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.109.192644</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ATMVQ8V">Circulation</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="1640" to="1645" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alberti K, Eckel RH, Grundy SM, et al.; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epi- demiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640-1645.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_Ung8DcH">Metabolic syndrome update</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Grundy</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tcm.2015.10.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8zSZEqP">Trends Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="364" to="373" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26:364-373.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_6Nnvrv4">The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials</title>
		<author>
			<persName><forename type="first">C</forename><surname>Arambepola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ricci-Cabello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Manikavasagam</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.5425</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TSySX2t">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">86</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arambepola C, Ricci-Cabello I, Manikavasagam P, et al. The impact of automated brief messages pro- moting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res. 2016;18:e86.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_XFWZX8w">Effectiveness of short message service text-based smoking cessation intervention among university students: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">U</forename><surname>Mussener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bendtsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Karlsson</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.8260</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TGsB8Wp">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="321" to="328" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mussener U, Bendtsen M, Karlsson N, et al. Effectiveness of short message service text-based smoking cessation intervention among university stu- dents: a randomized clinical trial. JAMA Intern Med. 2016;176:321-328.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_dDe42te">Healthcare via cell phones: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Krishna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Boren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Balas</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2008.0099</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4abatjJ">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="231" to="240" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009;15:231-240.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_JHrQZzx">Improved blood pressure control using an interactive mobile phone support system</title>
		<author>
			<persName><forename type="first">U</forename><surname>Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kjellgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hallberg</surname></persName>
		</author>
		<idno type="DOI">10.1111/jch.12682</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KhA5uvm">J Clin Hypertens</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2016">2016</date>
			<pubPlace>Greenwich)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Bengtsson U, Kjellgren K, Hallberg I, et al. Improved blood pressure control using an interactive mobile phone support system. J Clin Hypertens (Greenwich). 2016;18:101-108.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_yBcQMtw">Effect of lifestylefocused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2015.10945</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ySb8xNF">JAMA</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="page" from="1255" to="1263" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle- focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314:1255-1263.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_Cyzk6AR">Indices of need and social deprivation for primary health care</title>
		<author>
			<persName><forename type="first">M</forename><surname>Malmstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sundquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bajekal</surname></persName>
		</author>
		<idno type="DOI">10.1177/14034948980260021301</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K3dEwEx">Scand J Soc Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="124" to="130" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Malmstrom M, Sundquist J, Bajekal M, et al. Indices of need and social deprivation for primary health care. Scand J Soc Med. 1998;26:124-130.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_QRQfHTw">Ambulatory care groups: a categorization of diagnoses for research and management</title>
		<author>
			<persName><forename type="first">B</forename><surname>Starfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mumford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ykdRkp6">Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="53" to="74" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Starfield B, Weiner J, Mumford L, et al. Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res. 1991;26: 53-74.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main" xml:id="_vbET8MY">Kunskapscentrum levnadsvanor och sjukdomsprevention</title>
		<idno type="DOI">10.1093/ww/9780199540884.013.u19534</idno>
		<ptr target="https://vardgi-vare.skane.se/vardriktlinjer/levnadsvanor/#7090" />
		<imprint>
			<date type="published" when="2019-01-17">2019 Jan 17. 2019 Jan 17</date>
			<pubPlace>Levnadsvanor; Region Skåne</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Kunskapscentrum levnadsvanor och sjukdomspreven- tion. Levnadsvanor: Region Skåne; 2019 Jan 17 [updated 2019 Jan 17. Available from: https://vardgi- vare.skane.se/vardriktlinjer/levnadsvanor/#7090</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main" xml:id="_M6w9huv">Kostråd och matvanor</title>
		<author>
			<persName><surname>Livsmedelsverket</surname></persName>
		</author>
		<ptr target="https://www.livsmedelsverket.se/matvanor-halsa-miljo/kos-trad-och-matvanor" />
		<imprint>
			<date type="published" when="2018-11-06">2018 Nov 6</date>
			<publisher>Livsmedelsverket</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Livsmedelsverket. Kostråd och matvanor. Livsmedelsverket; 2018 Nov 6. Available from: https:// www.livsmedelsverket.se/matvanor-halsa-miljo/kos- trad-och-matvanor</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_P5psVxr">Adults&apos; sedentary behavior determinants and interventions</title>
		<author>
			<persName><forename type="first">N</forename><surname>Owen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sugiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Eakin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2011.05.013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fwrs4bt">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Owen N, Sugiyama T, Eakin EE, et al. Adults&apos; seden- tary behavior determinants and interventions. Am J Prev Med. 2011;41:189-196.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_myQ5Z7D">ESC/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mancia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fagard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Narkiewicz</surname></persName>
		</author>
		<idno type="DOI">10.1080/08037050701461084</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dq8SETQ">Blood Pressure</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="193" to="278" />
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESC/ESC guidelines for the management of arterial hyperten- sion: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Pressure. 2013;22:193-278.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_YheCqH8">Relationship of self-rated health with fatal and nonfatal outcomes in cardiovascular disease: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mavaddat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sanderson</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0103509</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cnPVDAe">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">103509</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mavaddat N, Parker RA, Sanderson S, et al. Relationship of self-rated health with fatal and non- fatal outcomes in cardiovascular disease: a systematic review and meta-analysis. PLoS One. 2014;9:e103509.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_hepNNsA">Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Pickard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Golicki</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11136-012-0322-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y6VPSbF">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1717" to="1727" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D- 3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717-1727.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_PhGxeCa">Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Herdman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gudex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lloyd</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11136-011-9903-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7UAywtQ">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1727" to="1736" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20: 1727-1736.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_EephTKJ">Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets</title>
		<author>
			<persName><forename type="first">B</forename><surname>Van Hout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Feng</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jval.2012.02.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nFwvsn9">Value Health</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="708" to="715" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Hout B, Janssen MF, Feng YS, et al. Interim scor- ing for the EQ-5D-5L: mapping the EQ-5D-5L to EQ- 5D-3L value sets. Value Health. 2012;15:708-715.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_AZ9zPwp">A tutorial on pilot studies: the what, why and how</title>
		<author>
			<persName><forename type="first">L</forename><surname>Thabane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chu</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2288-10-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mw6rPVH">BMC Med Res Methodol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thabane L, Ma J, Chu R, et al. A tutorial on pilot stud- ies: the what, why and how. BMC Med Res Methodol. 2010;10:1.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_CszTtQt">Statistics notes: analysing controlled trials with baseline and follow up measurements</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Vickers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.323.7321.1123</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rRnm2X7">BMJ</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="1123" to="1124" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vickers AJ, Altman DG. Statistics notes: analysing con- trolled trials with baseline and follow up measure- ments. BMJ. 2001;323:1123-1124.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_pKajjBV">Implementation of clinical practice guidelines on lifestyle interventions in Swedish primary healthcarea two-year follow up</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kardakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jerden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Nystrom</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12913-018-3023-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xms7zjS">BMC Health Serv Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">227</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kardakis T, Jerden L, Nystrom ME, et al. Implementation of clinical practice guidelines on life- style interventions in Swedish primary healthcare -a two-year follow up. BMC Health Serv Res. 2018;18: 227.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_QsyBe3F">The dilemma of patient responsibility for lifestyle change: perceptions among primary care physicians and nurses</title>
		<author>
			<persName><forename type="first">P</forename><surname>Jallinoja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Absetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuronen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Qu7mPr7">Scand J Prim Health Care</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="244" to="249" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jallinoja P, Absetz P, Kuronen R, et al. The dilemma of patient responsibility for lifestyle change: perceptions among primary care physicians and nurses. Scand J Prim Health Care. 2007;25:244-249.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_w5xVMbe">Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR]). A Single-Blind. Randomized Trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bobrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Springer</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.115.017530</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_djy9H4V">Circulation</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="592" to="600" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bobrow K, Farmer AJ, Springer D, et al. Mobile phone text messages to support treatment adherence in adults with high blood pressure (SMS-Text Adherence Support [StAR]). A Single-Blind. Randomized Trial. Circulation. 2016;133:592-600.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main" xml:id="_SrRugZ5">Cochrane Handbook for Systematic Reviews of Interventions</title>
		<author>
			<orgName type="collaboration">The Cochrane Collaboration</orgName>
		</author>
		<idno type="DOI">10.1002/9780470712184.index</idno>
		<ptr target="https://handbook-5-1.cochrane.org/index.htm#part_2_general_methods_for_cochrane_reviews.htm" />
		<imprint>
			<date type="published" when="2011-03">2011 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. 2011 Mar. Available from: https://handbook-5-1.cochrane.org/index.htm#part_ 2_general_methods_for_cochrane_reviews.htm</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
